Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 13;75(8):1558-1565.
doi: 10.1093/gerona/glz209.

Systemic Tumor Necrosis Factor-Alpha Trajectories Relate to Brain Health in Typically Aging Older Adults

Affiliations

Systemic Tumor Necrosis Factor-Alpha Trajectories Relate to Brain Health in Typically Aging Older Adults

Cutter A Lindbergh et al. J Gerontol A Biol Sci Med Sci. .

Abstract

Background: Central nervous system levels of tumor necrosis factor-alpha (TNF-α), a pro-inflammatory cytokine, regulate the neuroinflammatory response and may play a role in age-related neurodegenerative diseases. The longitudinal relation between peripheral levels of TNF-α and typical brain aging is understudied. We hypothesized that within-person increases in systemic TNF-α would track with poorer brain health outcomes in functionally normal adults.

Methods: Plasma-based TNF-α concentrations (pg/mL; fasting morning draws) and magnetic resonance imaging were acquired in 424 functionally intact adults (mean age = 71) followed annually for up to 8.4 years (mean follow-up = 2.2 years). Brain outcomes included total gray matter volume and white matter hyperintensities. Cognitive outcomes included composites of memory, executive functioning, and processing speed, as well as Mini-Mental State Examination total scores. Longitudinal mixed-effects models were used, controlling for age, sex, education, and total intracranial volume, as appropriate.

Results: TNF-α concentrations significantly increased over time (p < .001). Linear increases in within-person TNF-α were longitudinally associated with declines in gray matter volume (p < .001) and increases in white matter hyperintensities (p = .003). Exploratory analyses suggested that the relation between TNF-α and gray matter volume was curvilinear (TNF-α 2p = .002), such that initial increases in inflammation were associated with more precipitous atrophy. There was a negative linear relationship of within-person changes in TNF-α to Mini-Mental State Examination scores over time (p = .036) but not the cognitive composites (all ps >.05).

Conclusion: Systemic inflammation, as indexed by plasma TNF-α, holds potential as a biomarker for age-related declines in brain health.

Keywords: Brain aging; Cognition; Gray matter volume; Inflammation; Neuroimaging.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Curvilinear relationship of within-person changes in TNF‐α to total GMV. To visualize the quadratic effect, the mixed-effects model was refit with all predictors centered except the within-person terms. Predicted values from that model were then plotted, thus displaying the curve of a subject with a typical (average) trajectory in the present sample. The x-axis depicts within-person change in TNF‐α (pg/mL) whereas the y-axis depicts corresponding total GMV values (L). As illustrated by the curve, initial increases in inflammatory status were associated with more precipitous GMV decline, which eventually plateaued. GMV = Gray matter volume; TNF‐α = Tumor necrosis factor‐alpha.
Figure 2.
Figure 2.
Linear relationship of within-person changes in TNF‐α to WMH. The x-axis depicts within-person change in TNF‐α (pg/mL) whereas the y-axis depicts corresponding WMH volumes (logarithmically transformed to meet assumptions of normality) with 95% confidence intervals. As illustrated in the graph, increases in TNF‐α over time were significantly associated with increases in WMH burden. TNF‐α = Tumor necrosis factor‐alpha; WMH = White matter hyperintensity.

Similar articles

Cited by

References

    1. Franceschi C, Bonafè M, Valensin S, et al. . Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254. doi: 10.1111/j.1749-6632.2000.tb06651.x - PubMed
    1. McNerlan SE, Ross OA, Maeve Rea I.. Cytokine Expression and Production Changes in Very Old Age. Cham, Switzerland: Springer International Publishing; 2018. doi: 10.1007/978-3-319-64597-1_40-1
    1. Fougère B, Boulanger E, Nourhashémi F, Guyonnet S, Cesari M. Chronic inflammation: accelerator of biological aging. J Gerontol A Biol Sci Med Sci. 2016;72:1218–1225. doi: 10.1093/gerona/glw240 - PubMed
    1. Fenn AM, Norden DM, Godbout JP.. Neuroinflammation in Aging. Cham, Switzerland: Springer International Publishing; 2015. doi: 10.1002/9781118732748.ch6
    1. Cortese GP, Barrientos RM, Maier SF, Patterson SL. Aging and a peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLCgamma1, and ERK in hippocampal synaptoneurosomes. J Neurosci. 2011;31:4274–4279. doi: 10.1523/JNEUROSCI.5818-10.2011 - PMC - PubMed

Publication types